StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30573% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Recognized from beginning deferred revenue by Quarter

Recognized from beginning deferred revenue — Grants (legacy) ($M) ($M)

Moderna Recognized from beginning deferred revenue: -$1M in Q4 2024. No newer figure appears in the documents we track.

Latest, Q4 2024
-1
Period ended Dec 31, 2024
Change on a year earlier
–
0 in Q4 2023
History
16 quarters
Since Q1 2021
Sources
16
Documents cited below

Where the Q4 2024 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2025-02-21) ↗

Reported in Form 10-Q / 10-K Contract Liabilities.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRecognized from beginning deferred revenue — Grants (legacy) ($M) ($M)Year on yearSource
Q4 2024Dec 31, 2024-1–Form 10-K (filed 2025-02-21) ↗
Q3 2024Sep 30, 20248+300.0%Form 10-Q (filed 2024-11-07) ↗
Q2 2024Jun 30, 20240–Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 20240–Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 20230–Form 10-K (filed 2024-02-23) ↗
Q3 2023Sep 30, 20232–Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20230–Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 20230–Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 20220-100.0%Form 10-K (filed 2023-02-24) ↗
Q3 2022Sep 30, 20220-100.0%Form 10-Q (filed 2022-11-03) ↗
Q2 2022Jun 30, 20220-100.0%Form 10-Q (filed 2022-08-03) ↗
Q1 2022Mar 31, 20220-100.0%Form 10-Q (filed 2022-05-04) ↗
Q4 2021Dec 31, 2021-8–Form 10-K (filed 2022-02-25) ↗
Q3 2021Sep 30, 202110–Form 10-Q (filed 2021-11-04) ↗
Q2 2021Jun 30, 20218–Form 10-Q (filed 2021-08-05) ↗
Q1 2021Mar 31, 20212–Form 10-Q (filed 2021-05-06) ↗

Cite this data

StockData. (2026). Moderna Recognized from beginning deferred revenue ($M), quarterly Q1 2021–Q4 2024 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/def-rev-rec-grant-leg

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.